Silver Oak Securities Incorporated Buys Shares of 1,638 Masimo Corporation (NASDAQ:MASI)

Silver Oak Securities Incorporated acquired a new stake in Masimo Corporation (NASDAQ:MASI - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 1,638 shares of the medical equipment provider's stock, valued at approximately $268,000.

Several other institutional investors also recently modified their holdings of the company. FMR LLC raised its holdings in Masimo by 19.8% in the 4th quarter. FMR LLC now owns 8,097,454 shares of the medical equipment provider's stock valued at $1,338,509,000 after acquiring an additional 1,340,836 shares during the period. Vanguard Group Inc. increased its stake in shares of Masimo by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 4,586,702 shares of the medical equipment provider's stock worth $758,182,000 after purchasing an additional 66,215 shares during the period. Capital Research Global Investors lifted its holdings in Masimo by 80.5% during the 4th quarter. Capital Research Global Investors now owns 2,454,975 shares of the medical equipment provider's stock worth $405,807,000 after purchasing an additional 1,094,647 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Masimo by 119.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,735,167 shares of the medical equipment provider's stock valued at $286,823,000 after buying an additional 943,001 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. increased its position in Masimo by 8.9% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,662,376 shares of the medical equipment provider's stock worth $274,791,000 after buying an additional 135,888 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on MASI. BTIG Research set a $193.00 price target on shares of Masimo and gave the company a "buy" rating in a research note on Wednesday, May 7th. Raymond James Financial lowered their target price on shares of Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a report on Wednesday, May 7th. Wells Fargo & Company cut their price target on Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a research note on Wednesday, May 7th. Wall Street Zen lowered Masimo from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Masimo currently has an average rating of "Moderate Buy" and a consensus target price of $191.60.

Insiders Place Their Bets

In other news, COO Bilal Muhsin sold 10,000 shares of Masimo stock in a transaction on Monday, May 12th. The shares were sold at an average price of $163.28, for a total transaction of $1,632,800.00. Following the transaction, the chief operating officer now owns 24,172 shares in the company, valued at approximately $3,946,804.16. The trade was a 29.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 16.90% of the company's stock.

Masimo Price Performance

Shares of MASI traded up $2.15 during midday trading on Tuesday, hitting $170.27. The company's stock had a trading volume of 863,144 shares, compared to its average volume of 639,461. The company has a quick ratio of 1.62, a current ratio of 2.17 and a debt-to-equity ratio of 0.67. Masimo Corporation has a one year low of $101.61 and a one year high of $194.88. The stock has a market capitalization of $9.23 billion, a price-to-earnings ratio of -18.57 and a beta of 1.19. The company's fifty day simple moving average is $159.39 and its two-hundred day simple moving average is $166.74.

Masimo (NASDAQ:MASI - Get Free Report) last issued its earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 EPS for the quarter, topping the consensus estimate of $1.24 by $0.12. Masimo had a positive return on equity of 22.56% and a negative net margin of 25.06%. The firm had revenue of $372.00 million during the quarter, compared to the consensus estimate of $367.79 million. During the same quarter in the previous year, the firm earned $0.77 earnings per share. The business's quarterly revenue was down 24.5% on a year-over-year basis. As a group, equities analysts expect that Masimo Corporation will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.